SCHEMBL31099441

SCHEMBL31099441

CC(=O)NCCCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.56
SIRT5 Q9NXA8 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
ERAP2 Q6P179 1/20 0.44
ERAP1 Q9NZ08 1/20 0.44
LNPEP Q9UIQ6 1/20 0.44
ALDH1A1 P00352 1/20 0.44
NOD1 Q9Y239 2/20 0.44
GNPAT O15228 1/20 0.42
SIRT6 Q8N6T7 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SLC7A5 Q01650 1/20 0.41
CPB2 Q96IY4 2/20 0.41
CAPN1 P07384 1/20 0.41
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
PGGT1B P53609 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29589379 0.87 NPY4R (0.52) FOLH1ERAP2ERAP1LNPEPNOD1
SCHEMBL30915565 0.86 FOLH1 (0.61) FOLH1SIRT5SMN1; SMN2NOD1GNPAT
SCHEMBL27903157 0.85 FOLH1 (0.47) FOLH1ERAP2ERAP1LNPEPNOD1
SCHEMBL1711582 0.85 FOLH1 (0.47) FOLH1ERAP2ERAP1LNPEPNOD1
SCHEMBL29714926 0.85 FOLH1 (0.47) FOLH1ERAP2ERAP1LNPEPNOD1
SCHEMBL30919262 0.85 FOLH1 (0.51) FOLH1SIRT5SMN1; SMN2ALDH1A1NOD1
SCHEMBL13670128 0.84 FOLH1 (0.56) FOLH1SIRT5SMN1; SMN2NOD1SIRT6
SCHEMBL29394341 0.83 FOLH1 (0.58) FOLH1SIRT5SMN1; SMN2NOD1GNPAT
SCHEMBL14075788 0.83 FOLH1 (0.58) FOLH1SIRT5SMN1; SMN2NOD1GNPAT
SCHEMBL1711266 0.83 ERAP2 (0.58) FOLH1ERAP2ERAP1LNPEPNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4684807-A1 LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE Duality Biologics (Shanghai) Co., Ltd. (CN) 2026-01-28 EP claimed
CN-119300868-A Camptothecins compound and conjugate thereof, preparation method and application thereof 映恩生物科技(上海)有限公司 2025-01-10 CN claimed
CN-119053607-A Camptothecins compound and conjugate thereof, preparation method and application thereof 映恩生物科技(上海)有限公司 2024-11-29 CN claimed
WO-2024193692-A1 LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE 映恩生物制药(苏州)有限公司 2024-09-26 WO claimed
CN-118681035-A Ligand drug conjugate and preparation method and application thereof 映恩生物制药(苏州)有限公司 2024-09-24 CN claimed
CN-118684724-A Linker and use thereof in ligand drug conjugates 映恩生物制药(苏州)有限公司 2024-09-24 CN claimed
CN-122080121-A Linker and use thereof in ligand drug conjugates 2026-05-26 CN disclosed
EP-4684807-A1 LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE Duality Biologics (Shanghai) Co., Ltd. (CN) 2026-01-28 EP disclosed
CN-119300868-A Camptothecins compound and conjugate thereof, preparation method and application thereof 映恩生物科技(上海)有限公司 2025-01-10 CN disclosed
CN-119053607-A Camptothecins compound and conjugate thereof, preparation method and application thereof 映恩生物科技(上海)有限公司 2024-11-29 CN disclosed
WO-2024193692-A1 LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE 映恩生物制药(苏州)有限公司 2024-09-26 WO disclosed
CN-118681035-A Ligand drug conjugate and preparation method and application thereof 映恩生物制药(苏州)有限公司 2024-09-24 CN disclosed
CN-118684724-A Linker and use thereof in ligand drug conjugates 映恩生物制药(苏州)有限公司 2024-09-24 CN disclosed